Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | RECQL | P46063 | 2/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 3/20 | 0.32 |
| ▸ | HTR7 | P34969 | 3/20 | 0.32 |
| ▸ | HTR1A | P08908 | 3/20 | 0.32 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.32 |
| ▸ | HTR6 | P50406 | 2/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.31 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26225285 | 0.89 | MAPT (0.36) | L3MBTL1MAPTLMNAKDM4ETDP1 | |
| SCHEMBL26225284 | 0.89 | MAPT (0.36) | L3MBTL1MAPTLMNAKDM4ETDP1 | |
| SCHEMBL25836476 | 0.87 | MAPT (0.34) | L3MBTL1MAPTLMNAKDM4ETDP1 | |
| SCHEMBL26225294 | 0.82 | MAPT (0.38) | L3MBTL1MAPTLMNAKDM4ETDP1 | |
| SCHEMBL23791883 | 0.81 | L3MBTL1 (0.39) | L3MBTL1MAPTLMNAKDM4ETDP1 | |
| SCHEMBL22897396 | 0.80 | L3MBTL1 (0.37) | L3MBTL1MAPTLMNAKDM4ETDP1 | |
| SCHEMBL22897421 | 0.78 | MCL1 (0.37) | L3MBTL1MAPTKDM4ETDP1MEN1 | |
| SCHEMBL29425555 | 0.78 | MCL1 (0.37) | L3MBTL1MAPTKDM4ETDP1MEN1 | |
| SCHEMBL10348443 | 0.77 | MAPT (0.51) | L3MBTL1MAPTLMNAKDM4EMEN1 | |
| SCHEMBL10348410 | 0.77 | MAPT (0.51) | L3MBTL1MAPTLMNAKDM4EMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230355833-A1 | RADIOPAQUE POLYMERS | BIOCOMPATIBLES UK LIMITED (GB) | 2023-11-09 | — | — | US | disclosed |
| US-20230355833-A1 | RADIOPAQUE POLYMERS | BIOCOMPATIBLES UK LIMITED (GB) | 2023-11-09 | — | — | US | disclosed |
| US-11744916-B2 | Radiopaque polymers | BIOCOMPATIBLES UK LIMITED | 2023-09-05 | — | — | US | disclosed |
| US-11744916-B2 | Radiopaque polymers | BIOCOMPATIBLES UK LIMITED | 2023-09-05 | — | — | US | disclosed |
| US-11702498-B2 | Radiopaque polymers | BIOCOMPATIBLES UK LIMITED | 2023-07-18 | — | — | US | disclosed |
| US-11702498-B2 | Radiopaque polymers | BIOCOMPATIBLES UK LIMITED | 2023-07-18 | — | — | US | disclosed |
| EP-4130105-A1 | BIODEGRADABLE POLYMER | Biocompatibles UK Limited (GB) | 2023-02-08 | — | — | EP | disclosed |
| US-20210277162-A1 | RADIOPAQUE POLYMERS | Boston Scientific Medical Device Limited (IE) | 2021-09-09 | — | — | US | disclosed |
| US-20210115171-A1 | RADIOPAQUE POLYMERS | Boston Scientific Medical Device Limited (IE) | 2021-04-22 | — | — | US | disclosed |
| US-20210015963-A1 | RADIOPAQUE POLYMERS | BIOCOMPATIBLES UK LTD. (GB) | 2021-01-21 | — | — | US | disclosed |
| WO-2021009734-A1 | RADIOPAQUE POLYMERS | BIOCOMPATIBLES UK LIMITED (GB) | 2021-01-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210115171-A1 | RADIOPAQUE POLYMERS | C9, PARG, RAD50 | L3MBTL1 751/4885MAPT 2112/4885LMNA 739/4885 |
| US-11702498-B2 | Radiopaque polymers | OXER1, NR5A1, AQP1 | L3MBTL1 3906/4885MAPT 4575/4885LMNA 3358/4885 |
| US-20230355833-A1 | RADIOPAQUE POLYMERS | TPO, PGLS, IQGAP1 | L3MBTL1 2122/4885MAPT 4511/4885LMNA 3452/4885 |
| US-20210015963-A1 | RADIOPAQUE POLYMERS | TPO, PGLS, IQGAP1 | L3MBTL1 2122/4885MAPT 4511/4885LMNA 3452/4885 |
| US-11744916-B2 | Radiopaque polymers | TPO, PGLS, IQGAP1 | L3MBTL1 2122/4885MAPT 4511/4885LMNA 3452/4885 |
| US-20210277162-A1 | RADIOPAQUE POLYMERS | OXER1, NR5A1, AQP1 | L3MBTL1 3960/4885MAPT 4605/4885LMNA 3337/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.